Sophie Miczek

Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years

B. Autran, Y. Yazdanpanah, A. Duhamel, 2022, The Lancet Regional Health - Europe.

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People

A. Duhamel, A. Dendooven, D. Deplanque, 2021, Frontiers in Immunology.

Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection

A. Duhamel, A. Dendooven, D. Deplanque, 2021, bioRxiv.

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2, and cellular immune responses 3 months after booster vaccination

B. Autran, Y. Yazdanpanah, A. Dendooven, 2022, Clinical Microbiology and Infection.

Journal Pre-proof Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2, and cellular immune responses 3 months after booster vaccination

Yazdan, A. Dendooven, A. Goffard, 2022 .